Title : Use of K-Ras as a predictive biomarker for selecting anti-EGF receptor/pathway treatment.

Pub. Date : 2010 Aug

PMID : 20701442






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Additional studies in non-small-cell lung cancer have suggested that the k-ras mutation may be a negative predictor of response to the EGF receptor tyrosine kinase inhibitors erlotinib and gefitinib. Gefitinib ret proto-oncogene Homo sapiens